Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium in COPD of Different Severity
NCT00274573Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2002
- Primary completion
- Oct 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Tiotropium Arm with Placebo Arm (2 arms). Primary endpoints: Trough Forced Expiratory Volume in one second at 12 weeks and Forced Expiratory Volume in one second 2 hours post inhalation at 12 weeks. Started Mar 2002; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00274573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274573.